Clinical Trials in Houston

Showing 9681-9700 of 17,885 trials

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

NCT00171158

This extension II study allowed for further follow-up of the disease under treatment with imatinib mesylate and allow the participants to continue to receive imatinib mesylate.

Philadelphia Chromosome Positive CML

Novartis Pharmaceuticals260 participantsStarted Jul 1999

Chicago, Illinois, United States • Boston, Massachusetts, United States • Houston, Texas, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

NCT03242252

Primary Objective: To demonstrate the superiority of Sotagliflozin 200 milligrams (mg) and Sotagliflozin 400 mg versus placebo on HbA1c reduction at 26 Weeks in participants with Type 2 diabetes who have inadequate glycemic control and moderate renal impairment. Secondary Objectives: * To assess the effects of Sotagliflozin 200 mg and 400 mg versus placebo with respect to additional measures of glycemic control, blood pressure, and body weight. * To evaluate the safety of Sotagliflozin 200 mg and 400 mg versus placebo.

Type 2 Diabetes MellitusChronic Kidney Disease Stage 3

Lexicon Pharmaceuticals787 participantsStarted Aug 2017

Birmingham, Alabama, United States • Guntersville, Alabama, United States • Phoenix, Arizona, United States +167 more locations

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Find Trials by Condition in Houston

High Resolution Imaging for Early and Better Detection of Bladder Cancer

Evaluation of the Tissue Genesis Icellator Cell Isolation System to Treat Erectile Dysfunction

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors

Safety and Efficacy of SPD465 in Adults With ADHD

Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

Evaluate the Use of Liposuction and Cell Separation Devices for Autologous Fat (Adipose) Derived Cells to Treat the Symptoms of Erectile Dysfunction

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

CKDu in Sugarcane Workers in Guatemala